Kee Song Bio-Technology Holdings Limited announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 706.378 million compared to TWD 666.120 million a year ago. Operating loss was TWD 60.677 million compared to operating Income of TWD 21.387 million a year ago. Net loss was TWD 125.322 million compared to net income of TWD 7.787 million a year ago. Basic loss per share was TWD 3.4 compared to basic earnings per share of TWD 0.21 a year ago. For the nine months, sales was TWD 2,116.036 million compared to TWD 1,895.168 million a year ago. Operating loss was TWD 35.833 million compared to operating Income of TWD 100.176 million a year ago. Net loss was TWD 117.055 million compared to net income of TWD 53.380 million a year ago. Basic loss per share was TWD 3.18 compared to basic earnings per share of TWD 1.46 a year ago. Diluted loss per share was TWD 3.18 compared to diluted earnings per share of TWD 1.4 a year ago.